Pathologic studies demonstrate that kidney tubule injury, atrophy, and fibrosis are common features of chronic kidney disease (CKD) and are highly predictive of progression to dialysis. Established CKD risk factors including hypertension and advanced age are associated with tubular injury and fibrosis on biopsy. However, current clinical assessment of CKD evaluates only glomerular function (GFR) and glomerular injury (albuminuria), but not kidney tubular dysfunction or injury. The overall hypothesis of this application is that kidney tubular dysfunction and injury are measurable contributors to CKD pathogenesis and prognosis. Dysfunction of the kidney tubules will be assessed by three indices: (1) renal tubule resistance to hormone actions of FGF23 and PTH;(2) acid/base homeostasis;and (3) urine protein reabsorptive capacity. FGF23 and PTH are hormones that induce phosphaturia through effects on kidney tubules. FGF23 can directly cardiac toxicity, however it may also mark kidney dysfunction. In our preliminary work, we have demonstrated that elevated levels of FGF-23 or PTH are more strongly associated with adverse outcomes among persons with concomitantly lower urine phosphorus excretion. These findings suggest that indexing FGF23 and PTH to urine phosphorus identifies individuals with renal tubules that are resistant to these hormonal signals. Abnormal acid/base homeostasis and incomplete reabsorption of filtered proteins from the urine are additional markers of tubule dysfunction that may also be important for prognosis in persons with CKD. In addition, we have investigated several novel urinary proteins that are specific to renal tubular injury. Among community-living individuals without acute kidney injury, we have observed that higher urine concentrations of two markers (KIM-1 and IL-18) are associated with incident development of CKD and risk of death and heart failure, independent of eGFR or albuminuria. Collectively, these results have led us to hypothesize that an assessment of kidney tubular health that incorporates assessments of tubular dysfunction and injury could develop into a major advance in our assessment and management of CKD. Kidney tubular disease would capture a nonglomerular axis of CKD, and could help identify patients at greatest risk for CKD progression and CVD events. To address these objectives, we propose an ancillary study to the SPRINT trial - a large, NIH-sponsored, multi-center randomized clinical trial testing whether intensive (<120 mmHg) vs. standard (<140 mmHg) systolic blood pressure targets result in lower CVD events and rates of CKD progression. Among 2,566 SPRINT participants with eGFR <60ml/min/1.73m2 at baseline, we will: (1) determine the association of kidney tubular dysfunction and injury with risk of CVD events, (2) determine the association of kidney tubular dysfunction and injury with CKD progression, and (3) determine whether randomization to intensive blood pressure management arm of the trial slows progression of kidney tubular dysfunction and injury over time compared with standard blood pressure management.

Public Health Relevance

Currently, clinical assessment of chronic kidney disease (CKD) entails measurement of glomerular function (eGFR) and injury (albuminuria);these markers are strongly associated with CKD progression and cardiovascular disease (CVD) events. However, the kidney has many other non-glomerular functions. Kidney biopsy studies demonstrate that the degree of kidney tubular atrophy and fibrosis are extremely potent prognostic factors not captured by glomerular markers. This study will be conducted within a large multi-center randomized blood pressure trial with long-term follow-up and adjudicated CKD and CVD events. We propose to make non-invasive measurements of kidney tubular function and injury, and to test whether they inform prognosis of CVD events and CKD progression independent of eGFR and albuminuria. In addition, we will test whether randomization to intensive blood pressure management limits progression of tubular injury and dysfunction over time.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-J (O2))
Program Officer
Kimmel, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Veterans Medical Research Fdn/San Diego
San Diego
United States
Zip Code
Raphael, Kalani L; Gilligan, Sarah; Ix, Joachim H (2018) Urine Anion Gap to Predict Urine Ammonium and Related Outcomes in Kidney Disease. Clin J Am Soc Nephrol 13:205-212
Garimella, Pranav S; Bartz, Traci M; Ix, Joachim H et al. (2017) Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study. Am J Kidney Dis 69:744-751
Malhotra, Rakesh; Nguyen, Hoang Anh; Benavente, Oscar et al. (2017) Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis. JAMA Intern Med 177:1498-1505
Mehta, Tapan; Buzkova, Petra; Kizer, Jorge R et al. (2017) Higher plasma transforming growth factor (TGF)-? is associated with kidney disease in older community dwelling adults. BMC Nephrol 18:98
Park, M; Katz, R; Shlipak, M G et al. (2017) Urinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial. Am J Transplant 17:2640-2649
Hughes-Austin, Jan M; Rifkin, Dena E; Beben, Tomasz et al. (2017) The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals. Clin J Am Soc Nephrol 12:245-252
Dubin, Ruth F; Deo, Rajat; Bansal, Nisha et al. (2017) Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol 12:60-68
Kendrick, Jessica B; Zelnick, Leila; Chonchol, Michel B et al. (2017) Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis. Am J Nephrol 45:118-126
Raphael, Kalani L; Murphy, Rachel A; Shlipak, Michael G et al. (2016) Bicarbonate Concentration, Acid-Base Status, and Mortality in the Health, Aging, and Body Composition Study. Clin J Am Soc Nephrol 11:308-16
Lang, Joshua; Shlipak, Michael G (2016) Kidney Disease, Income, and Life Expectancy. Am J Kidney Dis 68:674-676

Showing the most recent 10 out of 14 publications